Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine versus dexmedetomidine for ICU delirium
ChiCTR2100049820Phase 4Completed
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olanzapine and dexmedetomidine in delirium (2 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoint: Survival days without delirium or coma. Started Aug 2021; status: completed.
02
Drugs
olanzapinedexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on ChiCTR2100049820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049820.